Seongnam-si, South Korea

Seung-Yong Seo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Seung-Yong Seo: Innovator in Pharmaceutical Compounds

Introduction

Seung-Yong Seo is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues such as obesity and diabetes. With a total of 4 patents to his name, Seo's work is recognized for its potential impact on medical treatments.

Latest Patents

Seo's latest patents include a novel 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof. This invention is particularly noteworthy as it exhibits GDH activity, making it effective for the prevention or treatment of obesity, diabetes, or fatty liver. Another significant patent involves ferrochelatase inhibitors and methods of use, which relate to treating patients with these inhibitors or their derivatives.

Career Highlights

Throughout his career, Seung-Yong Seo has worked with prestigious institutions such as Indiana University and Gachon University of Industry-Academic Cooperation Foundation. His research and innovations have contributed to advancements in pharmaceutical sciences, showcasing his dedication to improving health outcomes.

Collaborations

Seo has collaborated with notable individuals in his field, including Timothy William Corson and Bit Lee. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Seung-Yong Seo's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments that can significantly improve patient health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…